Delivery Order SPE2DB22D3004-SPE2DB25FPH21
Award Date
1/29/25
Potential Completion Date
2/20/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LORBRENA 100 MG TABLET 30S. The $21,930.68 contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a range of medical commodities to support military treatment programs...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNS44, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $11,344.30 firm fixed-price delivery order is for the pharmaceutical product LORBRENA 100 MG TABLET 30S, with a period of performance through December 26, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is delivering this product to support military treatment facilities, veterans'...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of LORBRENA 100 MG TABLET 30S, a brand name pharmaceutical product, with a total potential value of $21,156.78. The contract has a completion date of March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,930.68, is a Delivery Order for the supply of the pharmaceutical drug LORBRENA 100 MG TABLET 30S. The award has an Ultimate Completion Date of November 8, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $39,357.76 firm fixed price delivery order is for the pharmaceutical product Lynparza 100 mg tablets. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,519.62 firm fixed-price delivery order covers the procurement of 4567090102 ! LYNPARZA 100 MG TABLET UU 120S, with a period of performance through February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award with the ID SPE2DB22D3016|SPE2DB25FALJ5 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,039.24, is for the delivery of LYNPARZA 100 MG TABLET UU 120S, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 18, 2025. There was no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lynparza 150 mg tablets. The $19,741.74 firm-fixed price delivery order has a completion date of November 19, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,870.87 Firm Fixed Price Delivery Order is for the supply of LYNPARZA 150 MG TABLET UU 120S, a specialty medication. The contract has an ultimate completion date of July 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,212.02, is for the delivery of 4,566,761,034 units of the prescription drug Lynparza 150 mg tablet. The award has a completion date of January 10, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical...